Table of Contents
<< Previous Issue | Nov 2009 (Vol: 2009, Issue: 11) | Next Issue >> |
- Section: Licensing
-
Astellas and Medivation in Pact for Prostate Cancer Drug
-
Burgeoning Obesity Market Attracts Takeda and Amylin
-
Alder Signs Billion Dollar Deal with Bristol-Myers Squibb
-
Sanofi-aventis and Regeneron Extend Therapeutic Antibody Agreement
-
Abbott Acquires Rights for PanGenetics’ Analgesic
-
Another GSK and Nabi Deal Sends Positive Smoke Signals
- Section: Mergers & Acquisitions
-
Ligand Acquires Metabasis in Cash and CVR Deal
-
Swedish Companies Merge to Lead Niche Markets
-
Novartis Sets Eyes on Chinese Vaccine Market
-
Enzon Divests Specialty Business to Sigma-tau
-
Biota Accelerates Anti-infective Portfolio
-
Sciele Buys Partner Addrenex
- Section: Research & Development
-
Sanofi and Micromet Collaborate on Early Stage Cancer Antibody